This inventor holds 11 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kobe, JA (1976)
- Hyogo, JP (1980)
- Kawabe, JP (1990 - 1995)
- Inagawa, JP (1995)
- Inagawa-cho, JP (1996)
Company Filing History:
Years Active: 1976-1996
Title: Hirotomo Masuya: Innovator in Hydroquinone Derivatives
Introduction
Hirotomo Masuya is a prominent inventor based in Kawabe, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on hydroquinone derivatives. With a total of 11 patents to his name, Masuya has established himself as a key figure in the development of novel pharmacological compounds.
Latest Patents
Masuya's latest patents focus on hydroquinone derivatives and their intermediates. These novel compounds exhibit various pharmacological activities, including antioxidation in living organisms, making them valuable as medicaments. His work in this area has the potential to lead to significant advancements in medical treatments.
Career Highlights
Masuya is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His role at Takeda has allowed him to further his research and development efforts in the field of medicinal chemistry. His innovative approach and dedication to his work have contributed to the company's reputation for excellence in pharmaceutical research.
Collaborations
Masuya has collaborated with notable colleagues, including Masayoshi Yamaoka and Takuichi Miki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Hirotomo Masuya's contributions to the field of hydroquinone derivatives highlight his innovative spirit and commitment to advancing medicinal chemistry. His work continues to pave the way for new therapeutic options, demonstrating the importance of research and collaboration in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
